Why the study?
Does the performance and safety of a leadless intracardiac transcatheter pacing system differ between Japanese patients and patients from the rest of the world?
Does the performance and safety of a leadless intracardiac transcatheter pacing system differ between Japanese patients and patients from the rest of the world?
The leadless transcatheter pacing system demonstrated similar safety and efficacy in Japanese patients compared to the global population, despite differences in body size and implant procedures.
No takes yet. Share an insight, caveat, or question.
Supports similar leadless pacemaker safety in Japanese patients; leaves open prospective validation across populations.
Soejima et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: